Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Eanna Forde (Mayo, Ireland), Eanna Forde, Hilary Humphreys, Catherine Greene, Deirdre Fitzgerald-Hughes, Louise Sweeney, Ronan MacLoughlin, Marc Devocelle. LATE-BREAKING ABSTRACT: Host defence peptide prodrugs are respirable when delivered by vibrating mesh nebuliser. Eur Respir J 2015; 46: Suppl. 59, 3888

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: High expression of Midkine in the airways of patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Neutrophil elastase-activated host defence peptide prodrugs kill pseudomonas aeruginosa in a cystic fibrosis lung milieu Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: A modeling study Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 LATE-BREAKING ABSTRACT: Sweetening Antibiotic Treatment for Eradication of Bacteria Biofilm Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 LATE-BREAKING ABSTRACT: Tomoscintigraphic comparison of lung deposition with a vibrating-mesh and a jet nebulizer Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 LATE-BREAKING ABSTRACT: The differential pattern of deposition of nano-ranged particles in the airways of exposed workers Source: International Congress 2015 – Occupational and environmental exposure assessment and biomarkers Year: 2015 LATE-BREAKING ABSTRACT: Inhaled diesel exhaust alters immune response proteins in the bronchial secretome in humans Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Targeting Antibiotics to Pseudomonas aeruginosa in Small airways (TAPAS) in patients with Cystic Fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 LATE-BREAKING ABSTRACT: Reducing inflammation in the lung by targeting the endothelial cystic fibrosis transmembrane conductance regulator with copper-tobramycin Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 LATE-BREAKING ABSTRACT: Is there a relationship between use of inhaled antibiotics and prevalence of fungal isolates in the respiratory secretions of people with cystic fibrosis? A retrospective data analysis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Effect of I:E ratio on delivery of colistimethate sodium from breath-enhanced and breath-activated nebulizers Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 LATE-BREAKING ABSTRACT: Bacterial microbiota of mattress dust and nasal samples, farming exposure, and childhood asthma Source: International Congress 2015 – Occupational and environmental exposure assessment and biomarkers Year: 2015 Anaerobic bacteria and host defence in cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 LATE-BREAKING ABSTRACT: The use of in vitro Human Airway Epithelia for the development of novel antivirals against human rhinoviruses (HRV) Source: International Congress 2014 – Respiratory infections in children Year: 2014 Alternating inhaled antibiotic therapy in CF: A single center analysis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Histidinylated polylysines: An alternative antibacterial and fluidifying agent in cystic fibrosis.** Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 LATE-BREAKING ABSTRACT: Investigation of a novel small molecule furin inhibitor with regards Pseudomonas aeruginosa exotoxin A-induced cytotoxicity in human airways Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 LATE-BREAKING ABSTRACT: Complicated silicosis in an Australian worker from cutting engineered stone countertops: An embarrassing first for Australia Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015